创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

column
Recent Advances in Antiviral Medicinal Chemistry
ZHAN Peng, CHEN Fener
2024, 48(5): 321-324. DOI: 10.20053/j.issn1001-5094.2024.05.001
Abstract PDF
New Progress in HIV-1 Reverse Transcriptase Inhibitors (2021—2023)
ZENG Yi, ZHOU Jiaqi, BAO Yiling, LIU Jiayi, ZHANG Shuangshuang, GU Shuangxi
2024, 48(5): 325-334. DOI: 10.20053/j.issn1001-5094.2024.05.002
Abstract PDF
Recent Advances in Entry Inhibitors Targeting SARS-CoV-2 Spike Protein
GAO Heng, HU Lide, ZHANG Jiwei, JIA Huinan, ZHAN Peng, LIU Xinyong
2024, 48(5): 335-349. DOI: 10.20053/j.issn1001-5094.2024.05.003
Abstract PDF
Advances in Influenza Virus Inhibitors
LI Minke, YANG Boyao, WU Yixi, XU Chang, LIANG Huanhuan
2024, 48(5): 350-362. DOI: 10.20053/j.issn1001-5094.2024.05.004
Abstract PDF
Progress of Hepatitis C Virus Non-structural Protein 5B Polymerase Inhibitors
HAN Di, XUE Yiwei, LIU Fengxiang, ZHAN Peng, XU Yongtao
2024, 48(5): 363-377. DOI: 10.20053/j.issn1001-5094.2024.05.005
Abstract PDF
Research Progress of RNA Drug Delivery System Against Triple Negative Breast Cancer
LIU Kaiyue, LI Yaping, WANG Aiping, LANG Tianqun
2024, 48(5): 378-389. DOI: 10.20053/j.issn1001-5094.2024.05.006
Abstract PDF
Progress in the Structural Composition and Anti-tumor Effects of Peptide-Drug Conjugates
ZHANG Hui, LIU Chen, HAO Chaowei, XU Hanmei
2024, 48(5): 390-400. DOI: 10.20053/j.issn1001-5094.2024.05.007
Abstract PDF